Neonatal TPN Starter Bags Recalled Due to Sterility Assurance Failure
Central Admixture Pharmacy Services is recalling 427 bags of Neonatal TPN Starter Bag due to FDA concerns about sterility assurance. An FDA inspection questioned whether the product met required sterility standards.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall scores High because it involves a risk-of-harm product (neonatal parenteral nutrition for critically ill infants) where no illnesses or injuries have been reported. The recall is based on an FDA inspection that questioned sterility assurance, but no actual contamination or adverse events are confirmed in the source.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 427 bags of Neonatal TPN Starter Bag (Amino Acids Trophamine 3.5%/Dextrose 10% with Calcium and Heparin) in 250 mL single-use bags. The product is used as a parenteral nutrition (intravenous feeding) starter solution for neonates. The recall includes six lot numbers with expiration dates ranging from April 28, 2023 to May 20, 2023.
The recall was initiated because an FDA inspection raised questions about whether these sterile products actually met sterility standards. Lack of adequate sterility assurance in products intended for intravenous use presents a risk when administered to vulnerable neonatal patients.
The product was distributed nationwide throughout the United States. Healthcare providers, hospitals, and clinics that received these recalled lots should stop using them immediately. Affected facilities should check their inventory against the specific lot numbers and expiration dates listed and contact Central Admixture Pharmacy Services, Inc. for return or replacement instructions.
The recalled product
- Product
- Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3.5%/Dextrose 10% with CALCIUM and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0421-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Parenteral Nutrition
- Affected units
- 427
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lot # 37-893804
- Exp 04/28/2023
- 37-894713
- Exp 04/30/2023
- 37-896134
- Exp 05/06/2023
- 37-896497
- Exp 05/07/2023
- 37-897310
- Exp 05/12/2023
- 37-899623
- Exp 05/20/2023
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 108 recalled by Central Admixture Pharmacy Services, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 108 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services, Inc.
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
Same hazard · sterility defect
See all →- SevereLidocaine Hydrochloride Injection Recalled for Sterility Assurance
FDA (Drugs) · 2026-07-08
- SevereIMULDOSA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-08
- HighChloraPrep One-Step antiseptic solution sterility assurance recall
FDA (Drugs) · 2026-07-01
- ModerateCodman CerebroFlo EVD Catheter recalled for out-of-specification endotoxin
FDA (Devices) · 2026-05-20
- HighMedline Medical Procedure Kits with Neuro Sponges Recalled for Endotoxin
FDA (Devices) · 2026-05-06